When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
BPMC - Blueprint Medicines' pralsetinib shows positive action in RET-altered thyroid cancer
Blueprint Medicines Corporation
Blueprint Medicines (NASDAQ:BPMC) announces a pipeline update including topline data from the Phase 1/2 ARROW study evaluating pralsetinib (BLU-667) in patients with solid tumors.
More news on: Blueprint Medicines Corporation, Healthcare stocks news,